{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:30:40Z","timestamp":1787232640248,"version":"build-2736575974"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This narrative review aims to comprehensively synthesize recent advances in the immunopathological mechanisms and genetic landscape underlying pseudoaneurysm formation in Vascular Beh\u00e7et\u2019s Disease (VBD). We integrate key discoveries from 2010 to 2026 regarding genetic susceptibility, immune cell dysregulation, inflammatory mediator networks, and structural deterioration of the vascular wall. Unlike previous reviews that primarily focused on clinical manifestations and descriptive observations, this article proposes a multilevel pathogenic cascade model linking genetic predisposition to full-thickness vascular wall destruction. We critically evaluate current consensus and controversies, identify unresolved knowledge gaps, and highlight potential strategies for early risk stratification and precision intervention. These insights may provide a theoretical framework for addressing the clinical challenges associated with the high rupture risk and recurrence rate of VBD-associated pseudoaneurysms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      At the genetic level, the HLA-B51\/ERAP1 axis establishes a fundamental susceptibility background, while non-HLA genes, including TNFAIP3, IL10, and CCR1, contribute to fine-tuning immune regulatory thresholds. At the cellular level, excessive neutrophil NETosis, activation of THBS1\n                      <jats:sup>high<\/jats:sup>\n                      macrophages, aberrant Th17 responses, and disruption of the Treg\/effector T-cell balance collectively form a self-amplifying inflammatory network. Notably, THBS1\n                      <jats:sup>high<\/jats:sup>\n                      macrophages have been reported to provide single-cell-level evidence linking immune activation to aneurysm development by driving vascular smooth muscle cell (VSMC) phenotypic switching; however, this finding derives from a single-center exploratory study and awaits independent replication. At the inflammatory mediator level, TNF-\u03b1 functions as a central driver that cooperates with matrix metalloproteinase (MMP)-mediated extracellular matrix degradation, JAK\/STAT signaling, and the IL-23\/IL-17 axis\u00a0to\u00a0establish a highly interconnected pro-inflammatory signaling network.\u00a0At\u00a0the\u00a0vascular structural level, inflammation propagates from the adventitial\u00a0vasa\u00a0vasorum toward the inner vascular layers, accompanied by medial\u00a0elastic\u00a0fiber\u00a0disruption and VSMC phenotypic transition,\u00a0ultimately resulting\u00a0in\u00a0pseudoaneurysm formation. The YAP\/TAZ mechanotransduction pathway\u00a0further reinforces a vicious cycle between vascular expansion and inflammation. Current animal models, including herpes simplex virus (HSV)-induced models and HLA-B51 transgenic models, fail to consistently reproduce vascular phenotypes, representing a major barrier to mechanistic investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>VBD-associated pseudoaneurysm represents a multilevel pathogenic cascade driven by the interaction of genetic susceptibility, immune cell amplification, inflammatory mediator networks, and progressive vascular wall degeneration. Integrated stratification based on immunological and genetic biomarkers may enable early identification of high-risk patients and facilitate individualized therapeutic strategies. Targeting the THBS1\u2013macrophage axis and the NETs\u2013IL-17A inflammatory circuit may represent a promising direction for precision intervention, although substantial translational barriers remain. Future studies should prioritize the development of vascular phenotype\u2013relevant animal models, conduct dedicated genetic investigations focused on pseudoaneurysm susceptibility, and integrate multi-omics approaches to bridge mechanistic discoveries with clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1930449","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:10:19Z","timestamp":1787231419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Beh\u00e7et\u2019s Disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanfei","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2025.106983","article-title":"Beh\u00e7et syndrome","volume":"165","author":"Espinosa","year":"2025","journal-title":"Med Clinica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.21.07490-5","article-title":"Vascular complications of Beh\u00e7et disease","volume":"112","author":"Tazi Mezalek","year":"2021","journal-title":"Minerva Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3400\/avd.ra.18-00002","article-title":"What is vascular Beh\u00e7et's disease","volume":"11","author":"Ishibashi","year":"2018","journal-title":"Ann Vasc Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.200170","article-title":"Vascular involvement in Beh\u00e7et's disease: the immunopathological process","volume":"20","author":"de Vargas","year":"2021","journal-title":"Jornal Vasc Brasileiro"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2022.11.011","article-title":"Vascular manifestations of Behcet's disease","volume":"44","author":"Tazi Mezalek","year":"2023","journal-title":"La Rev M\u00e9decine Interne"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72429","article-title":"Beh\u00e7et's disease and aneurysms: a case series of vascular involvement and outcomes","volume":"16","author":"Shah","year":"2024","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S567674","article-title":"Vascular involvement in Beh\u00e7et's disease: a retrospective analysis of Qatar Beh\u00e7et's cohort","volume":"18","author":"Saleh","year":"2026","journal-title":"Open Access Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12916-025-04434-y","article-title":"THBS1high macrophages promote aortic aneurysm formation by orchestrating an inflammatory and smooth muscle cell phenotypic transition program in vascular Beh\u00e7et's disease","volume":"23","author":"Sun","year":"2025","journal-title":"BMC Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/BOR.0000000000001067","article-title":"Omics studies in Beh\u00e7et's disease","volume":"37","author":"Ozguler","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab052","article-title":"Distinct transcriptional profile of blood mononuclear cells in Beh\u00e7et's disease: insights into the central role of neutrophil chemotaxis","volume":"60","author":"Verrou","year":"2021","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13023-019-1061-1","article-title":"Demography of vascular Behcet's disease with different gender and age: an investigation with 166 Chinese patients","volume":"14","author":"Chen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3349\/ymj.2023.0578","article-title":"Cardiovascular manifestations in Beh\u00e7et's disease","volume":"65","author":"Kim","year":"2024","journal-title":"Yonsei Med J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02637-1","article-title":"Arterial and venous involvement in Beh\u00e7et's syndrome: a narrative review","volume":"54","author":"Toledo-Samaniego","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jvs.2025.02.006","article-title":"Optimal timing of surgical treatment for Behcet's disease aortic or peripheral artery pseudoaneurysms","volume":"82","author":"Wu","year":"2025","journal-title":"J Vasc Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2022.07.904","article-title":"HLA-B51 impact on clinical symptoms in Behcet's disease","volume":"32","author":"Pamukcu","year":"2022","journal-title":"J Coll Physicians Surgeons Pakistan"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222277","article-title":"Beh\u00e7et's disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity","volume":"81","author":"Cavers","year":"2022","journal-title":"Ann Rheumatic Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222852","article-title":"EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders","volume":"82","author":"Kuiper","year":"2023","journal-title":"Ann Rheumatic Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13075-018-1613-0","article-title":"GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Beh\u00e7et's disease","volume":"20","author":"Nakano","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14715\/cmb\/2016.62.3.11","article-title":"Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: a meta-analysis","volume":"62","author":"Lee","year":"2016","journal-title":"Cell Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2013.437","article-title":"Insertion\/deletion polymorphism of the ACE gene increased risk of Behcet disease: evidence from a meta-analysis","volume":"33","author":"Mandal","year":"2013","journal-title":"Ann Saudi Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-58605-9","article-title":"Identification of DNA sequence variants in the vasculo-Behcet disease patient using whole exome sequencing: a pilot study from Pakistan","author":"Waqas","year":"2026","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s42358-023-00328-w","article-title":"The roles of immune cells in Beh\u00e7et's disease","volume":"63","author":"Hu","year":"2023","journal-title":"Adv Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease","volume":"78","author":"Le Joncour","year":"2019","journal-title":"Ann Rheumatic Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590622","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in Beh\u00e7et's disease","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e213","article-title":"Neutrophil-mediated thrombosis and NETosis in Beh\u00e7et's disease: a hypothesis","volume":"35","author":"Batu","year":"2020","journal-title":"J Korean Med Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.70217","article-title":"CD177+ neutrophils promote endothelial senescence through extracellular traps in Beh\u00e7et disease","author":"Wang","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411524","article-title":"NETs-CD44-IL-17A feedback loop drives Th17-mediated inflammation in Beh\u00e7et's uveitis","volume":"12","author":"Wu","year":"2025","journal-title":"Adv Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109785","article-title":"Plasma-derived exosomal protein SHP2 deficiency induces neutrophil hyperactivation in Behcet's uveitis","volume":"239","author":"Cai","year":"2024","journal-title":"Exp Eye Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874467215666220324114624","article-title":"Immunomodulatory therapeutic effects of curcumin on M1\/M2 macrophage polarization in inflammatory diseases","volume":"16","author":"Abdollahi","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108683","article-title":"Aberrant monocyte subsets in patients with Beh\u00e7et's disease","volume":"225","author":"Li","year":"2021","journal-title":"Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2015.54745","article-title":"Serum IL-17A in Beh\u00e7et's disease","volume":"32","author":"Emiroglu","year":"2015","journal-title":"Postepy Dermatologii i Alergologii"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102920","article-title":"Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet's uveitis","volume":"133","author":"Deng","year":"2022","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S547283","article-title":"Single-cell transcriptomics reveals CCL3+ classical monocyte subset linked to autoimmune pathogenesis","volume":"18","author":"Xu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14471","article-title":"Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders","volume":"45","author":"Kanekura","year":"2018","journal-title":"J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13778","article-title":"Efficacy of TNF\u03b1 inhibitors for refractory vascular Beh\u00e7et's disease: a multicenter observational study of 27 patients and a review of the literature","volume":"23","author":"Aksoy","year":"2020","journal-title":"Int J Rheumatic Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.080325.tav","article-title":"The effectiveness of infliximab in treating vascular manifestations of Beh\u00e7et's disease: a systematic review and meta-analysis","volume":"36","author":"Bennani","year":"2025","journal-title":"Mediterr J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2024.11049","article-title":"New and future perspectives in Beh\u00e7et's syndrome","volume":"39","author":"Sulu","year":"2024","journal-title":"Arch Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2026.2676066","article-title":"New insights into the management of Beh\u00e7et syndrome","volume":"35","author":"Esatoglu","year":"2026","journal-title":"Expert Opin Invest Drugs"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911078","article-title":"Role of extracellular matrix and inflammation in abdominal aortic aneurysm","volume":"23","author":"Stepien","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2024.08.274","article-title":"Inflammation in abdominal aortic aneurysm: cause or comorbidity","volume":"40","author":"Zhu","year":"2024","journal-title":"Can J Cardiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170845","article-title":"Vascular smooth muscle-specific YAP\/TAZ deletion triggers aneurysm development in mouse aorta","volume":"8","author":"Ar\u00e9valo Mart\u00ednez","year":"2023","journal-title":"JCI Insight"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110549","article-title":"Etiopathogenesis of Beh\u00e7et's disease: a systematic literature review","volume":"279","author":"Belfeki","year":"2025","journal-title":"Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1109147","article-title":"Chemokines and chemokine receptors in Beh\u00e7et's disease","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2014.64","article-title":"Activation of the JAK\/STAT pathway in Behcet's disease","volume":"16","author":"Tulunay","year":"2015","journal-title":"Genes Immun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2026.153025","article-title":"Efficacy and safety of JAK inhibitors in Beh\u00e7et syndrome: systematic literature review","volume":"80","author":"Sulu","year":"2026","journal-title":"Semin Arthritis Rheumatism"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303316226240823045641","article-title":"Interpreting the function of the IL-23\/IL-17 axis through bioinformatics","volume":"25","author":"Vazquez-Jimenez","year":"2025","journal-title":"Endocrine Metab Immune Disord Drug Targets"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740637","article-title":"Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis","volume":"122","author":"Merashli","year":"2022","journal-title":"Thromb Haemostasis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.70216","article-title":"Asprosin as a potential link between vascular inflammation and disease activity in Beh\u00e7et's disease","volume":"40","author":"Kaya","year":"2026","journal-title":"J Clin Lab Anal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2024.104692","article-title":"Endothelial dysfunction and complement activation are independently associated with disease duration in patients with systemic vasculitis","volume":"154","author":"Dolgyras","year":"2024","journal-title":"Microvasc Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/metabo16060363","article-title":"Plasma lipidomic remodeling in Beh\u00e7et's disease reveals alterations associated with vascular involvement","volume":"16","author":"Ko\u00e7ak","year":"2026","journal-title":"Metabolites"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2174\/1389450119666180122154409","article-title":"Hypoperfusion of the aortic wall secondary to degeneration of adventitial vasa vasorum causes abdominal aortic aneurysms","volume":"19","author":"Tanaka","year":"2018","journal-title":"Curr Drug Targets"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2408223","article-title":"Angiogenesis in aortic aneurysm and dissection: a literature review","volume":"24","author":"Jia","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx4374","article-title":"Vasa vasorum plexus formation in intracranial aneurysm associates with microcalcification and wall thickening","volume":"11","author":"Abdurakhmonov","year":"2025","journal-title":"Sci Adv"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158309","article-title":"BAF60c prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis","volume":"132","author":"Zhao","year":"2022","journal-title":"J Clin Invest"},{"key":"B58","article-title":"Vitamin D3 ameliorates herpes simplex virus-induced Beh\u00e7et's disease-like inflammation in a mouse model through down-regulation of Toll-like receptors","volume":"29","author":"Choi","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16047413","article-title":"The relevance of miRNA-21 in HSV-induced inflammation in a mouse model","volume":"16","author":"Choi","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.07.004","article-title":"IL-2\/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model","volume":"220","author":"Choi","year":"2015","journal-title":"Immunobiology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13102","article-title":"The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Beh\u00e7et's disease mouse model","volume":"158","author":"Sayeed","year":"2019","journal-title":"Immunology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/638273","article-title":"Immunopathogenic role of herpes simplex virus in Beh\u00e7et's disease","volume":"2013","author":"Kim","year":"2013","journal-title":"Genet Res Int"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895869","article-title":"Candidate drugs screening for Behcet's disease based on bioinformatics analysis and mouse experiments","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheumatic Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930449\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:10:20Z","timestamp":1787231420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930449\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2026.1930449"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1930449","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1930449"}}